Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:04 PM
Ignite Modification Date:
2025-12-24 @ 1:04 PM
NCT ID:
NCT02973061
Eligibility Criteria:
Inclusion Criteria:
* Children over the age of 6 years, and less than 16 years
* Children eligible for rhGH treatment according to the following Food and Drug Administration approved indications; Small for gesational age, Idioapathic short stature, GH deficiency and chronic renal failure.
* Consent of parents / guardian to participate in research
Exclusion Criteria:
* \- Under the age of 6 years and above 16 years
* Previously diagnosed with neurocognitive disease
* Previously diagnosed with specific syndromes: Prader-willi syndrome, Turner
* Previously diagnosed with Attention Deficit/Hyperactivity disorder
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
16 Years
Study:
NCT02973061
Study Brief:
Protocol Section:
NCT02973061